Zyprexa era comes to an end for Lilly
On Oct. 24, the U.S. Food and Drug Administration approved the first generic versions of Eli Lilly and Co.’s best-seller, ending 15 years of highly lucrative sales.
On Oct. 24, the U.S. Food and Drug Administration approved the first generic versions of Eli Lilly and Co.’s best-seller, ending 15 years of highly lucrative sales.
Hill-Rom Holdings Inc. posted better-than-expected earnings and revenue in its fiscal fourth quarter, the Batesville-based hospital-bed supplier announced Wednesday.
Cigna Corp. will buy fellow health insurer HealthSpring Inc. in a $3.8 billion deal as it becomes the latest managed care company to snap up a bigger share of the fast-growing Medicare Advantage market.
As constitutional challenges to the health reform law’s mandate to buy insurance advance, WellPoint Inc.’s chief financial officer reiterated that the company does not object to the mandate, just to its lack of penalties.
The hospitals owned by Boone and Hamilton counties are following the lead of Indianapolis-based Wishard Health Services and its parent organization by acquiring far-flung nursing homes, hoping the strategy proves as lucrative.
CBRE Inc. accuses the local hospital system of cheating it out of consulting fees that could top seven figures related to several building projects.
The Indiana Court of Appeals reversed a Marion Superior Court decision to dismiss a lawsuit by two uninsured patients who received care at IU Health North Hospital in Carmel.
Medicare supplement policies are reportedly one of the targets of Congress’ special deficit-reduction committee—and that’s not good news for Carmel-based CNO Financial Group Inc.
Remaining grant money will be invested to beef up the infrastructure of the Indiana Network for Patient Care, a health information exchange operated by the Indianapolis-based Regenstrief Institute.
Medical residents are getting more job offers than before, yet greater numbers of them say if they had it to do over again, they would not go to medical school.
Cialis, Lilly’s blockbuster erectile dysfunction drug, now can be taken to treat enlarged prostate. FDA approval means men who suffer from both disorders can take one medication.
When Jeanette Sabir-Holloway entered dental school at Indiana University in 1976, she was one of only three black students in a class of 120. She would be the only African-American to graduate with her class four years later.
Drugmaker Eli Lilly and Co. doesn’t plan to buy Pfizer Inc.’s $3.58 billion animal-health business, CEO John Lechleiter said Wednesday.
The Children’s Better Health Institute, a division of The Saturday Evening Post Society Inc., plans to ask the Metropolitan Development Commission to rezone a 23-acre parcel on the city’s northwest side.
The integration of the two not-for-profit hospital systems, approved by Howard Regional's board in late May, is now dead, the two hospitals announced Monday.
Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, is in talks with Mustafa Nevzat Ilac Sanayii AS to sell the Turkish company’s treatments in 26 countries, said Mustafa Nevzat’s CEO.
WellPoint Inc.’s participation in buying a majority stake of the private health insurance exchange operator Bloom Health could help it get back to its roots as a health insurer—and make a bit more money in the process.
Indiana University announced a partnership with the Indianapolis-based IU Health hospital system that will launch four primary care clinics in Bloomington, which can be visited for no extra charge by those enrolled in IU’s health plans.
Federal officials on Friday denied Indiana's request to use a state public health savings account to help cover the half-million people who will become eligible for Medicaid in 2014, saying the request was premature and leaving the state program's future in flux.
The new Indianapolis-based organization was formed by Nursing 2000, Nursing 2000 North and the Indiana Nursing Workforce Development Coalition, all of which focused on generating an adequate supply of well-trained nurses.